Skip to content

Author

Amirabas Bostani

We have 3 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

Naringenin Attenuates Diabetic Cardiac Injury via SIRT1 Activation in Streptozotocin‐Induced Rats

Objective Diabetic cardiomyopathy (DCM) lacks targeted therapies. This study investigated naringenin (NAR), a citrus flavonoid, in a streptozotocin (STZ)‐induced diabetic rat model with cardiac complications, focusing on SIRT1‐mediated mechanisms. Methods Rats (n = 8/group) included control, NAR, DCM, DCM + NAR, and DC...

Bao-Lan Wang, Dan-Dan Zhang, Fu-Dan Zhang et al. · 0 citations
Open access Sep 2026

Baicalein Attenuates Early Molecular and Proliferative Changes in MASH-Driven Hepatocarcinogenesis by Inhibiting the NLRP3 Inflammasome and Pyroptosis Pathway

Background Metabolic dysfunction-associated steatohepatitis (MASH) is a major risk factor for hepatocellular carcinoma (HCC). The nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and pyroptosis are key drivers of inflammation and tumorigenesis. Baicalein (BAI...

Jing Xu, Amirabas Bostani, Hong-Wei Qu · 0 citations
Open access Sep 2026

Ellagic Acid Enhances RSL3‐Induced Ferroptosis by Inhibiting the Nrf2/HO‐1 Signaling Pathway in Pancreatic Ductal Adenocarcinoma

EA potentiates RSL3‐induced ferroptosis in PDAC by disrupting the p38/Nrf2/HO‐1 axis and elevating Keap1, a natural compound‐based strategy overcomes redox‐driven resistance, offering a translatable approach for PDAC models.

Jian-Hua Bai, Yi-He Dai, Chern Ein Oon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.